pharmaceutical investing Cyclacel Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Sapacitabine With Olaparib in BRCA Mutant Breast Cancer
Element79 Gold Corp. Announces Filing of NI 43-101 Technical Report for Gold Mountain Project, Nevada